View in EDS

Individualized dynamic risk assessment and treatment selection for multiple myeloma.

Saved in:
Bibliographic Details
Title: Individualized dynamic risk assessment and treatment selection for multiple myeloma.
Authors: Murie C; Institute for Systems Biology, Seattle, WA, USA., Turkarslan S; Institute for Systems Biology, Seattle, WA, USA., Patel AP; Department of Neurosurgery, Duke University, Durham, NC, USA., Coffey DG; Division of Myeloma, University of Miami, Miami, FL, USA., Becker PS; Departments of Hematology and Hematopoietic Stem Cell Transplantation and Hematologic Malignancies Translational Science, City of Hope National Medical Center, Duarte, CA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA., Baliga NS; Institute for Systems Biology, Seattle, WA, USA. nitin.baliga@isbscience.org.; Molecular Engineering and Sciences Institute, University of Washington, Seattle, WA, USA. nitin.baliga@isbscience.org.; Departments of Biology and Microbiology, University of Washington, Seattle, WA, USA. nitin.baliga@isbscience.org.; Molecular and Cellular Biology Program, University of Washington, Seattle, WA, USA. nitin.baliga@isbscience.org.; Lawrence Berkeley National Lab, Berkeley, CA, USA. nitin.baliga@isbscience.org.
Source: British journal of cancer [Br J Cancer] 2025 Jun; Vol. 132 (10), pp. 922-936. Date of Electronic Publication: 2025 Apr 01.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40169765
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Individualized dynamic risk assessment and treatment selection for multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Murie+C%22">Murie C</searchLink>; Institute for Systems Biology, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Turkarslan+S%22">Turkarslan S</searchLink>; Institute for Systems Biology, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Patel+AP%22">Patel AP</searchLink>; Department of Neurosurgery, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Coffey+DG%22">Coffey DG</searchLink>; Division of Myeloma, University of Miami, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Becker+PS%22">Becker PS</searchLink>; Departments of Hematology and Hematopoietic Stem Cell Transplantation and Hematologic Malignancies Translational Science, City of Hope National Medical Center, Duarte, CA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Baliga+NS%22">Baliga NS</searchLink>; Institute for Systems Biology, Seattle, WA, USA. nitin.baliga@isbscience.org.; Molecular Engineering and Sciences Institute, University of Washington, Seattle, WA, USA. nitin.baliga@isbscience.org.; Departments of Biology and Microbiology, University of Washington, Seattle, WA, USA. nitin.baliga@isbscience.org.; Molecular and Cellular Biology Program, University of Washington, Seattle, WA, USA. nitin.baliga@isbscience.org.; Lawrence Berkeley National Lab, Berkeley, CA, USA. nitin.baliga@isbscience.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2025 Jun; Vol. 132 (10), pp. 922-936. <i>Date of Electronic Publication: </i>2025 Apr 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40169765
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-025-02987-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 922
    Titles:
      – TitleFull: Individualized dynamic risk assessment and treatment selection for multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Murie C
      – PersonEntity:
          Name:
            NameFull: Turkarslan S
      – PersonEntity:
          Name:
            NameFull: Patel AP
      – PersonEntity:
          Name:
            NameFull: Coffey DG
      – PersonEntity:
          Name:
            NameFull: Becker PS
      – PersonEntity:
          Name:
            NameFull: Baliga NS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Numbering:
            – Type: volume
              Value: 132
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1